Somatic features of response and relapse in non-muscle invasive bladder cancer treated with intravesical Bacillus Calmette-Guerin

被引：0
|
作者：
Muller, D. C. [1 ]
Bacon, J. V. W. [2 ]
Ritch, E. [2 ]
Dugas, S. G. [1 ]
Vandekerkhove, G. [2 ]
Annala, M. [3 ,4 ]
Black, P. C. [2 ]
Seifert, H. [1 ]
Bubendorf, L. [5 ]
Wyatt, A. W. [2 ]
Rentsch, C. A. [1 ]
机构：
[1] Univ Hosp Basel, Dept Urol, Basel, Switzerland
[2] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC, Canada
[3] Univ Tampere, Fac Med & Life Sci, Tampere, Finland
[4] Prostate Canc Res Ctr, BioMediTech Inst, Tampere, Finland
[5] Univ Hosp Basel, Inst Med Genet & Pathol, Basel, Switzerland
来源：
EUROPEAN UROLOGY | 2021年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P0445
引用
收藏
页码：S617 / S617
页数：1
相关论文
共 50 条
  • [1] Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin Immunotherapy
    Bacon, Jack V. W.
    Muller, David C.
    Ritch, Elie
    Annala, Matti
    Dugas, Sarah G.
    Herberts, Cameron
    Vandekerkhove, Gillian
    Seifert, Helge
    Zellweger, Tobias
    Black, Peter C.
    Bubendorf, Lukas
    Wyatt, Alexander W.
    Rentsch, Cyrill A.
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (06): : 677 - 686
  • [2] Impact of UTUC on Outcomes of Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guerin
    Bree, K. K.
    Hensley, P. J.
    Brooks, N.
    Matulay, J.
    Navai, N.
    Grossman, H. B.
    Matin, S. F.
    Dinney, C. P.
    Kamat, A. M.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 898 - 898
  • [3] NON-MUSCLE INVASIVE BLADDER CANCER SUBTYPES WITH DIFFERENTIAL RESPONSE TO INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT
    de Jong, Florus C.
    Laajala, Teemu D.
    Hoedemaeker, Robert F.
    Rinaldetti, Sebastien
    Jordan, Kimberley R.
    van der Made, Angelique C. J.
    Nieuwkamer, Bart
    van der Schoot, Deric K. E.
    Boeve, Egbert R.
    Janssen, Emiel A. M.
    Mahmoudi, Tokameh
    Boormans, Joost L.
    Theodorescu, Dan
    Costello, James C.
    Zuiverloon, Tahlita C. M.
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E77 - E77
  • [4] Non-muscle invasive bladder cancer subtypes with differential response to intravesical bacillus Calmette-Guerin treatment
    De, Jong F. C.
    Laajala, T. D.
    Hoedemaeker, R. F.
    Rinaldetti, S.
    Jordan, K.
    Van der Made, A. C. J.
    Nieuwkamer, B.
    Boeve, E. R.
    Janssen, E. A. M.
    Mahmoudi, T.
    Boormans, J. L.
    Theodorescu, D.
    Costello, J. C.
    Zuiverloon, T. C. M.
    [J]. EUROPEAN UROLOGY, 2022, 81 : S105 - S106
  • [5] Bacillus Calmette-Guerin treatment of non-muscle invasive bladder cancer
    Sylvester, Richard J.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (02) : 113 - 120
  • [6] Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer
    Wang, Ziting
    So, Wei Zheng
    Loh, Kep Yong
    Lim, Yew Koon
    Mahendran, Ratha
    Wu, Qing Hui
    Chiong, Edmund
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (08) : 807 - 815
  • [7] Impact of intravesical Bacillus Calmette-Guerin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
    James, Christopher
    Gomez, Kayeromi
    Desai, Shalin
    Patel, Hiten D.
    Rac, Goran
    Doshi, Chirag P.
    Dornbier, Ryan
    Bajic, Petar
    Halverson, Thomas
    Gupta, Gopal N.
    Quek, Marcus L.
    Gorbonos, Alex
    Flanigan, Robert
    Wolfe, Alan J.
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [8] Evaluation of sarcopenia in patients receiving intravesical Bacillus Calmette-Guerin for non-muscle invasive bladder cancer
    Alam, Syed M.
    Larson, Matthew
    Srinivasan, Pugazhendhi
    Genz, Nick
    Fleer, Ryan
    Sardiu, Mihaela
    Thompson, Jeffrey
    Lee, Eugene
    Hamilton-Reeves, Jill
    Wulff-Burchfield, Elizabeth
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (10) : 431.e15 - 431.e20
  • [9] Intravesical Thalidomide boosts bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer treatment
    Passos, Gabriela R.
    Camargo, Juliana A.
    Ferrari, Karen L.
    Saad, Mario J. A.
    de Mattos, Amilcar C.
    Reis, Leonardo O.
    [J]. MEDICAL ONCOLOGY, 2018, 35 (01)
  • [10] Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette-Guerin for patients with non-muscle invasive bladder cancer
    Obara, Wataru
    Hara, Isao
    Kato, Yoichiro
    Kato, Renpei
    Inoue, Keiji
    Sato, Fuminori
    Mimata, Hiromitsu
    Nakamura, Yusuke
    Fujioka, Tomoaki
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (09) : 1371 - 1380
12345